Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK conceals vCJD (variant Creutzfeldt-Jakob disease) surgery risks: paternalism or cover-up?

This article was originally published in Clinica

Executive Summary

A scientist involved in UK government-commissioned research into the state of decontamination and sterilisation facilities in hospitals and the associated risk of surgical transmission of variant Creutzfeldt-Jakob disease (vCJD) claims he was ordered to keep an interim report confidential and to destroy all evidence of the investigation, so "disturbing" were the initial findings. Scottish health authorities, however, published the report, which calls for "urgent action to remedy a series of major deficiencies".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel